Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

FluoGuide

37.80 SEK

+2.72 %

Less than 1K followers

FLUO

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+2.72 %
-5.50 %
-6.20 %
-8.03 %
-3.45 %
-3.32 %
-11.99 %
-54.98 %
+321.63 %

FluoGuide is a Danish company operating in the medical technology sector. The company's business focus is on research and development of treatments for various forms of cancer, with the greatest focus on the development of products that guide surgical procedures. The products bind to cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.

Read more
Market cap
618M SEK
Turnover
147.85K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25.2.
2026

Annual report '25

25.3.
2026

General meeting '26

27.5.
2026

Interim report Q1'26

All
Research
Webcasts
Press releases
ShowingAll content types
Press releaseyesterday

BioStock: FluoGuide highlights operational progress in Q3

FluoGuide
Press release11/27/2025, 6:56 PM

Redeye: FluoGuide (Q3 review) - Busy news flow

FluoGuide
Regulatory press release11/27/2025, 6:18 AM

FluoGuide A/S publishes Interim Report Q3 2025

FluoGuide

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release11/25/2025, 1:59 PM

FluoGuide signs collaboration agreement with ZEISS

FluoGuide
Regulatory press release11/24/2025, 3:14 PM

Minutes from Extraordinary General Meeting in FluoGuide A/S

FluoGuide
Press release11/24/2025, 10:05 AM

Invitation to FluoGuide A/S (Nasdaq: FLUO) webcast on 27 November 2025

FluoGuide
Press release11/11/2025, 10:43 AM

BioStock: FluoGuide accelerates precision cancer surgery

FluoGuide
Press release11/5/2025, 4:27 PM

FluoGuide strengthens leadership to advance clinical program and regulatory approval strategy

FluoGuide
Regulatory press release11/5/2025, 4:22 PM

FluoGuide convenes an extraordinary general meeting

FluoGuide
Regulatory press release11/3/2025, 8:54 PM

FluoGuide A/S issue warrants to board members, executive management and employees

FluoGuide
Regulatory press release11/3/2025, 8:30 PM

Share transfer and ownership restructuring – related party transaction

FluoGuide
Regulatory press release11/3/2025, 8:28 PM

FluoGuide A/S completes directed share issue of SEK 104 million

FluoGuide
Regulatory press release11/3/2025, 4:43 PM

FluoGuide A/S intends to carry out a directed share issue of approximately SEK 100 million

FluoGuide
Regulatory press release10/28/2025, 12:47 PM

FluoGuide in advanced negotiations on collaboration agreement with a world leading medical technology company

FluoGuide
Press release10/6/2025, 7:05 AM

Positive interim results from an investigator-initiated study of FG001 in meningioma and low-grade glioma surgery, presented at EANS

FluoGuide
Press release9/25/2025, 9:18 AM

BioStock: Video from Fluoguide's presentation at BioStock Investing in Life Science – From Seed to Success

FluoGuide
Regulatory press release9/16/2025, 9:01 AM

FluoGuide receives positive FDA feedback on FG001 in high-grade glioma

FluoGuide
Press release8/28/2025, 3:09 PM

Redeye: FluoGuide Q2 2025 - Gearing up for the next phase

FluoGuide
Regulatory press release8/28/2025, 5:28 AM

FluoGuide A/S publishes Interim Report H1 2025

FluoGuide
Press release8/22/2025, 10:51 AM

Invitation to FluoGuide A/S (Nasdaq: FLUO) webcast on 28 August 2025

FluoGuide
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.